Actively Recruiting
Hamburg Acute Kidney Injury Study Observing Hospitalized Adults With and Without AKI to Understand Kidney Injury and Outcomes
Led by Universitätsklinikum Hamburg-Eppendorf · Updated on 2026-10-01
1000
Participants Needed
1
Research Sites
208 weeks
Total Duration
AI-Summary
What This Trial Is About
The Hamburg Acute Kidney Injury Study HAKIS is a prospective observational cohort study focusing on adults aged 18 years and older who are hospitalized. The study investigates the mechanisms, risk factors, and clinical outcomes related to acute kidney injury AKI by comparing patients who develop AKI with those hospitalized for acute illnesses without AKI. The research aims to better understand kidney injury trajectories, identify biological pathways of kidney damage and repair, and improve risk assessment and prognostic tools to enhance post-AKI care. Participants are divided into two groups those with AKI meeting the 2012 KDIGO criteria and a control group without AKI but with acute illness. The study collects detailed clinical data, including kidney function, comorbidities, medications, procedures, and laboratory tests. Biosamples of blood and urine are gathered at enrollment, during hospitalization, and three months after discharge, then stored in specialized biobanks. No experimental treatments are given all care adheres to standard clinical practice. During the study, participants undergo serial assessments of kidney function and other health parameters at hospital discharge, at three months post-discharge, and during annual follow-ups. These evaluations include monitoring kidney recovery, progression to chronic kidney disease, cardiovascular events, hospital readmissions, and mortality. The study also tracks secondary outcomes such as vascular diseases, dementia, cancer, infections, and psychiatric conditions. Participation involves data and biosample collection over multiple visits, with no changes to usual medical care.
CONDITIONS
Brief Title
Hamburg Acute Kidney Injury Study (HAKIS)
Research Team
C
Christian Schmidt-Lauber, MD
M
Maja Lindenmeyer, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here